ATE329032T1 - Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff - Google Patents

Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff

Info

Publication number
ATE329032T1
ATE329032T1 AT01913816T AT01913816T ATE329032T1 AT E329032 T1 ATE329032 T1 AT E329032T1 AT 01913816 T AT01913816 T AT 01913816T AT 01913816 T AT01913816 T AT 01913816T AT E329032 T1 ATE329032 T1 AT E329032T1
Authority
AT
Austria
Prior art keywords
vaccine
membrane protein
haemophilus influenza
external membrane
relates
Prior art date
Application number
AT01913816T
Other languages
English (en)
Inventor
Francois-Xavier Jacque Berthet
Institut L
Philippe Denoel
Jan Poolman
Joelle Thonnard
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE329032T1 publication Critical patent/ATE329032T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01913816T 2000-02-15 2001-02-13 Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff ATE329032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0003502.2A GB0003502D0 (en) 2000-02-15 2000-02-15 Vaccine

Publications (1)

Publication Number Publication Date
ATE329032T1 true ATE329032T1 (de) 2006-06-15

Family

ID=9885665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01913816T ATE329032T1 (de) 2000-02-15 2001-02-13 Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff

Country Status (10)

Country Link
US (3) US20030096370A1 (de)
EP (1) EP1254234B1 (de)
JP (1) JP4815090B2 (de)
AT (1) ATE329032T1 (de)
AU (1) AU2001239262A1 (de)
CA (1) CA2399480C (de)
DE (1) DE60120357T2 (de)
ES (1) ES2264438T3 (de)
GB (1) GB0003502D0 (de)
WO (1) WO2001061013A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
EA014352B1 (ru) 2005-08-10 2010-10-29 Арне Форсгрен Аб Взаимодействие moraxella catarrhalis с эпителиальными клетками, внеклеточными матриксными белками и системой комплемента
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
EP2405938A2 (de) * 2009-02-13 2012-01-18 Intercell AG Nicht typisierbare haemophilus influenza-antigene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812613D0 (en) * 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
DE60120357T2 (de) 2007-06-06
US20060251671A1 (en) 2006-11-09
JP4815090B2 (ja) 2011-11-16
US7811590B2 (en) 2010-10-12
EP1254234A1 (de) 2002-11-06
GB0003502D0 (en) 2000-04-05
US20090175912A1 (en) 2009-07-09
JP2003522543A (ja) 2003-07-29
DE60120357D1 (de) 2006-07-20
US20030096370A1 (en) 2003-05-22
EP1254234B1 (de) 2006-06-07
ES2264438T3 (es) 2007-01-01
CA2399480A1 (en) 2001-08-23
CA2399480C (en) 2011-11-15
WO2001061013A1 (en) 2001-08-23
AU2001239262A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
AP2001002199A0 (en) Novel streptococcus antigens
MXPA03000103A (es) Antigenos de streptococcus.
DK1093517T3 (da) Neisseria-meningitidis-antigener og præparater
DE69922958D1 (de) Hcv hüllproteine partikel : verwendung für therapeutische impfung
BR0010720A (pt) Peptìdeos de neisseria antigênicos
DE69533544D1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
NO20006191L (no) Vaksine
ATE466093T1 (de) Rekombinanter adeno-assoziierter virusvektor zur behandlung von morbus alzheimer
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
DE60039050D1 (de) Antigene meningokokken peptide
WO1999042588A3 (en) Group b streptococcus antigens
WO2004006952A3 (en) Therapeutic tuberculosis vaccines
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DE60118359D1 (de) Humanische pellino-polypeptide
EP1613345A4 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
ATE329032T1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
DK0680765T3 (da) Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme
EP1499349A4 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
ATE281524T1 (de) Moraxella catarrhalis pilq proteine
DE60037413D1 (de) Rekombinante adhesin-proteine aus haemophilus influenzae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties